Antimicrobials in polymethylmethacrylate: from prevention to prosthetic joint infection treatment: basic principles and risk of resistance
暂无分享,去创建一个
E. Muñoz-Mahamud | L. Morata | J. Martínez-Pastor | A. Soriano | E. Guerra‐Farfán | M. Sabater-Martos | Miguel Verdejo
[1] Ke Jie,et al. Comprehensive meta-analysis of antibiotic-impregnated bone cement versus plain bone cement in primary total knee arthroplasty for preventing periprosthetic joint infection , 2022, Chinese journal of traumatology = Zhonghua chuang shang za zhi.
[2] E. Schwarz,et al. Skeletal infections: microbial pathogenesis, immunity and clinical management , 2022, Nature Reviews Microbiology.
[3] A. Craig,et al. Articular spacers in two-stage revision arthroplasty for prosthetic joint infection of the hip and the knee , 2022, EFORT open reviews.
[4] E. Vasarhelyi,et al. Static vs Articulating Spacers for Two-Stage Revision Total Knee Arthroplasty: Minimum Five-Year Review , 2022, Arthroplasty today.
[5] O. Savvidou,et al. Current Concepts on the Application, Pharmacokinetics and Complications of Antibiotic-Loaded Cement Spacers in the Treatment of Prosthetic Joint Infections , 2022, Cureus.
[6] The Effect of Antibiotic Loaded Bone Cement on Risk of Revision, Following Hip and Knee Arthoplasty: A Systematic Review and Meta-analysis , 2021, OrthoMedia.
[7] A. Blocker,et al. In vitro antibiotic activity against intraosteoblastic Staphylococcus aureus: a narrative review of the literature , 2021, The Journal of antimicrobial chemotherapy.
[8] R. Sousa,et al. Combined antibiotic therapy spacers either commercial or handmade are superior to monotherapy – a microbiological analysis at the second stage of revision , 2021, Journal of bone and joint infection.
[9] B. Giraudeau,et al. Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection. , 2021, The New England journal of medicine.
[10] Á. Soriano,et al. Fluorescent tetracycline bone labeling as an intraoperative tool to debride necrotic bone during septic hip revision: a preliminary case series , 2021, Journal of bone and joint infection.
[11] O. Furnes,et al. Antibiotic-Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty: A Register-based Multicentre Randomised Controlled Non-inferiority Trial (ALBA trial) , 2021, BMJ Open.
[12] Sameer S. Kadri,et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. , 2020, The Lancet. Infectious diseases.
[13] M. Whooley,et al. Antibiotic-Laden Bone Cement Use and Revision Risk After Primary Total Knee Arthroplasty in U.S. Veterans. , 2020, The Journal of bone and joint surgery. American volume.
[14] R. G. Richards,et al. Three-Dimensional In Vitro Staphylococcus aureus Abscess Communities Display Antibiotic Tolerance and Protection from Neutrophil Clearance , 2020, Infection and Immunity.
[15] T. O’Neill,et al. Is the use of antibiotic-loaded bone cement associated with a lower risk of revision after primary total hip arthroplasty? , 2020, The bone & joint journal.
[16] M. Bue,et al. Pathological and microbiological impact of a gentamicin-loaded biocomposite following limited or extensive debridement in a porcine model of osteomyelitis , 2020, Bone & joint research.
[17] L. Lidgren,et al. Antibiotic containing bone cement in prevention of hip and knee prosthetic joint infections: A systematic review and meta-analysis , 2020, Journal of orthopaedic translation.
[18] M. Bhandari,et al. Antibiotic Cement in Arthroplasty: A Meta-analysis of Randomized Controlled Trials , 2020, Cureus.
[19] Á. Soriano,et al. When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus. , 2020, The Journal of antimicrobial chemotherapy.
[20] J. Parvizi,et al. Adjuvant antibiotic‐loaded bone cement: Concerns with current use and research to make it work , 2020, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[21] E. Schwarz,et al. Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis , 2019, Current Osteoporosis Reports.
[22] P. Baker,et al. Antibiotic-loaded bone cement is associated with a lower risk of revision following primary cemented total knee arthroplasty: an analysis of 731,214 cases using National Joint Registry data. , 2019, The bone & joint journal.
[23] S. Gill,et al. Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy” , 2019, Bone Research.
[24] J. Collins,et al. Definitions and guidelines for research on antibiotic persistence , 2019, Nature Reviews Microbiology.
[25] A. Charlett,et al. Staphylococcal resistance profiles in deep infection following primary hip and knee arthroplasty: a study using the NJR dataset , 2019, Archives of Orthopaedic and Trauma Surgery.
[26] Michael A. Mont,et al. Routine use of commercial antibiotic-loaded bone cement in primary total joint arthroplasty: a critical analysis of the current evidence. , 2019, Annals of translational medicine.
[27] Á. Soriano,et al. Failure After 2-Stage Exchange Arthroplasty for Treatment of Periprosthetic Joint Infection: The Role of Antibiotics in the Cement Spacer. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] K. L. de Mesy Bentley,et al. Vancomycin-Loaded Polymethylmethacrylate Spacers Fail to Eradicate Periprosthetic Joint Infection in a Clinically Representative Mouse Model , 2018, The Journal of bone and joint surgery. American volume.
[29] J. Parvizi,et al. Changes in Antibiotic Susceptibility of Staphylococcus aureus Between the Stages of 2-Stage Revision Arthroplasty. , 2018, The Journal of arthroplasty.
[30] M. Reed,et al. Antibiotic resistance profiles of deep surgical site infections in hip hemiarthroplasty; comparing low dose single antibiotic versus high dose dual antibiotic impregnated cement , 2016, Journal of bone and joint infection.
[31] M. Bue,et al. Suppurative Inflammation and Local Tissue Destruction Reduce the Penetration of Cefuroxime to Infected Bone Implant Cavities. , 2017, Journal of comparative pathology.
[32] A. Nocon,et al. Success rates, characteristics, and costs of articulating antibiotic spacers for total knee periprosthetic joint infection. , 2017, The Knee.
[33] M. Bue,et al. Novel porcine model of implant‐associated osteomyelitis: A comprehensive analysis of local, regional, and systemic response , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[34] M. A. Rosa,et al. Peri-Prosthetic Knee Infection Management: Spacers Loaded with Two or Three Antibiotic Agents. , 2017, Surgical infections.
[35] S. Kates,et al. Evidence of Staphylococcus Aureus Deformation, Proliferation, and Migration in Canaliculi of Live Cortical Bone in Murine Models of Osteomyelitis , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] N. Parsons,et al. The use of high-dose dual-impregnated antibiotic-laden cement with hemiarthroplasty for the treatment of a fracture of the hip , 2016, The bone & joint journal.
[37] Dragan Radoicic,et al. Ertapenem Articulating Spacer for the Treatment of Polymicrobial Total Knee Arthroplasty Infection , 2016, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.
[38] Sandrine Colas,et al. Association Between Total Hip Replacement Characteristics and 3-Year Prosthetic Survivorship: A Population-Based Study. , 2015, JAMA surgery.
[39] X. Weng,et al. Antibiotic Bone Cement Cannot Reduce Deep Infection After Primary Total Knee Arthroplasty. , 2015, Orthopedics.
[40] J. Parvizi,et al. Staphylococcal Persistence Due to Biofilm Formation in Synovial Fluid Containing Prophylactic Cefazolin , 2015, Antimicrobial Agents and Chemotherapy.
[41] N. Larrosa,et al. Antibiotic susceptibility in gram-positive chronic joint arthroplasty infections: increased aminoglycoside resistance rate in patients with prior aminoglycoside-impregnated cement spacer use. , 2014, The Journal of arthroplasty.
[42] J. Parvizi,et al. Routine use of antibiotic laden bone cement for primary total knee arthroplasty: impact on infecting microbial patterns and resistance profiles. , 2014, The Journal of arthroplasty.
[43] M. Giers,et al. Distribution of molecules locally delivered from bone cement. , 2014, Journal of biomedical materials research. Part B, Applied biomaterials.
[44] E. Cáceres,et al. Industrially Prefabricated Cement Spacers: Do Vancomycin- and Gentamicin-impregnated Spacers Offer Any Advantage? , 2014, Clinical orthopaedics and related research.
[45] M. Dunbar,et al. Does Adding Antibiotics to Cement Reduce the Need for Early Revision in Total Knee Arthroplasty? , 2014, Clinical orthopaedics and related research.
[46] M. Itoman,et al. Two-Stage Revision Total Hip Arthroplasty for Periprosthetic Infections Using Antibiotic-Impregnated Cement Spacers of Various Types and Materials , 2013, TheScientificWorldJournal.
[47] P. Guirro,et al. The use of erythromycin and colistin-loaded cement in total knee arthroplasty does not reduce the incidence of infection: a prospective randomized study in 3000 knees. , 2013, The Journal of bone and joint surgery. American volume.
[48] Michael R. Caplan,et al. Spatiotemporal Quantification of Local Drug Delivery Using MRI , 2013, Comput. Math. Methods Medicine.
[49] R. McLemore,et al. Distribution of Locally Delivered Antimicrobials Is Limited by Cortical Bone: A Pilot Study , 2013, Clinical orthopaedics and related research.
[50] D. Iarikov,et al. Choice and doses of antibacterial agents for cement spacers in treatment of prosthetic joint infections: review of published studies. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] R. McLemore,et al. Mixing Method Affects Elution and Strength of High-dose ALBC: A Pilot Study , 2012, Clinical orthopaedics and related research.
[52] B. Rogers,et al. Does cyclical loading affect the elution of antibiotics from articulating cement knee spacers? , 2011, The Journal of bone and joint surgery. British volume.
[53] J. Parvizi. Periprosthetic joint infection. , 2011, Orthopedics.
[54] D. Fithian,et al. Outcomes of routine use of antibiotic-loaded cement in primary total knee arthroplasty. , 2009, The Journal of arthroplasty.
[55] R. McLemore,et al. Hand-mixed and Premixed Antibiotic-loaded Bone Cement Have Similar Homogeneity , 2009, Clinical orthopaedics and related research.
[56] L. Lidgren,et al. Microbiology of the infected knee arthroplasty: Report from the Swedish Knee Arthroplasty Register on 426 surgically revised cases , 2009, Scandinavian journal of infectious diseases.
[57] B. Vernon,et al. Generic Tobramycin Elutes From Bone Cement Faster Than Proprietary Tobramycin , 2008, Clinical Orthopaedics and Related Research.
[58] C. Shih,et al. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex™ cement spacers in two‐stage revision of infected hip implants: A study of 46 patients at an average follow‐up of 107 days , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[59] J. Kelm,et al. In Vivo and In Vitro Studies of Antibiotic Release from and Bacterial Growth Inhibition by Antibiotic-Impregnated Polymethylmethacrylate Hip Spacers , 2006, Antimicrobial Agents and Chemotherapy.
[60] J. V. van Horn,et al. Bacterial survival in the interfacial gap in gentamicin-loaded acrylic bone cements. , 2005, The Journal of bone and joint surgery. British volume.
[61] Mel S. Lee,et al. Two-stage revision hip arthroplasty for infection with a custom-made, antibiotic-loaded, cement prosthesis as an interim spacer. , 2004, The Journal of trauma.
[62] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[63] D. Bouchier‐Hayes,et al. Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. , 2002, The Journal of bone and joint surgery. British volume.
[64] W. Lo,et al. Cefuroxime-Impregnated Cement in Primary Total Knee Arthroplasty: A Prospective, Randomized Study of Three Hundred and Forty Knees , 2002, The Journal of bone and joint surgery. American volume.
[65] G. O’Toole,et al. Mechanisms of biofilm resistance to antimicrobial agents. , 2001, Trends in microbiology.
[66] H. Busscher,et al. Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation , 2000, Acta orthopaedica Scandinavica.
[67] B. Masri,et al. Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. , 1998, The Journal of arthroplasty.
[68] B. Espehaug,et al. Antibiotic prophylaxis in total hip arthroplasty , 1997 .
[69] C. Duncan,et al. Persistence of bacteria on antibiotic loaded acrylic depots. A reason for caution. , 1996, Clinical orthopaedics and related research.
[70] S. Stern,et al. Total knee arthroplasty in diabetes mellitus. , 1990, Clinical orthopaedics and related research.
[71] M. McQueen,et al. Cefuroxime in total joint arthroplasty. Intravenous or in bone cement. , 1990, The Journal of arthroplasty.
[72] L. Lindberg,et al. Systemic antibiotics and gentamicin-containing bone cement in the prophylaxis of postoperative infections in total hip arthroplasty. , 1981, Clinical orthopaedics and related research.
[73] H. Tscherne,et al. [Results of prophylactic use of Refobacin-Palacos in implantation of endoprostheses of the hip joint in Hannover]. , 1979, Aktuelle Probleme in Chirurgie und Orthopadie.